The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy and safety of camrelizumab and apatinib combined with induction chemotherapy and concurrent chemoradiotherapy for stage TanyN3M0 nasopharyngeal carcinoma: A phase II QUINTUPLED trial.
 
Hu Liang
No Relationships to Disclose
 
Lin Wang
No Relationships to Disclose
 
Nian Lu
No Relationships to Disclose
 
Yao-Fei Jiang
No Relationships to Disclose
 
Jian-Wei Wang
No Relationships to Disclose
 
Wei-Xin Bei
No Relationships to Disclose
 
Liang-Ru Ke
No Relationships to Disclose
 
Yan-Fang Ye
No Relationships to Disclose
 
Guo-Ying Liu
No Relationships to Disclose
 
Wang-Zhong Li
No Relationships to Disclose
 
LiTing Liu
No Relationships to Disclose
 
Jin-Ling Duan
No Relationships to Disclose
 
Chong Zhao
No Relationships to Disclose
 
Weixiong Xia
No Relationships to Disclose
 
Xiang Yanqun
No Relationships to Disclose